Dr Simon J Clark, 'Molecular mechanisms driving Age-related Macular Degeneration: Understanding the role of complement.'
12:00pm - 12:45pm /
Friday 15th February 2019
/ Venue: G12-G15, William Henry Duncan Apex Building
- 0151 794 9003
- Brenda Smith
- Suitable for: The talk will appeal to anyone working in Ophthalmology and vision sciences, but also immunology and its regulation, as well as individuals involved in translations research in ocular therapeutics.
- Admission: Free to staff and students
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Simon is a protein biochemist who studies the regulation of the complement system and specialises in its role in age-related macular degeneration (AMD).
Genetic variants that dramatically increase risk of AMD are predominantly found in genes involved in complement activation. Simon will discuss how genetic risk leads to complement activation, how this helps drive AMD pathogenesis, and the therapeutic challenges faced when attempting to treat this debilitating disease.
Genetic variants that dramatically increase risk of AMD are predominantly found in genes involved in complement activation. Simon will discuss how genetic risk leads to complement activation, how this helps drive AMD pathogenesis, and the therapeutic challenges faced when attempting to treat this debilitating disease.